Live feed16:05:00·35dPRReleasevia QuantisnowArtiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic DiseasesByQuantisnow·Wall Street's wire, on your screen.ARTV· Artiva Biotherapeutics Inc.Health Care
